What is an antibody cocktail, is it effective against COVID-19, Zee explains
While vaccination continues to play a major role in combating the COVID-19 virus, doctors across the world have been using various other innovative medical techniques, therapies to treat coronavirus patients.
May 28, 2021, 16:03 PM IST
Roche, Cipla launch ‘Antibody Cocktail’ for treatment of mild to moderate COVID-19
Priced at Rs 59,750 per dose, the medicine consists of an amalgamation of Casirivimab and Imdevimab drugs. Cipla will take care of the distribution of the product.
May 24, 2021, 15:36 PM IST
Roche gets US FDA emergency use nod for coronavirus COVID-19 antibody test
Roche Holding AG received emergency use approval from the US Food and Drug Administration (FDA) for an antibody test to help determine if people have ever been infected with the coronavirus, the Swiss drugmaker said on Sunday.
May 03, 2020, 12:17 PM IST
Cancer drug: SC allows Cipla to withdraw appeal against Roche
The Supreme Court on Friday allowed domestic drug manufacturer Cipla, which recently arrived at a settlement with Swiss pharma major Roche over a lung cancer drug, to withdraw its petition on the patent row.
Jun 16, 2017, 15:18 PM IST
Roche launches new breast cancer drugs in India
Swiss drug major Roche has launched in India two new medicines for treating breast cancer claiming increased survival benefit and improved quality of life for patients.
Oct 12, 2015, 18:10 PM IST
